Armata Pharmaceuticals, Inc.

8-K Regulation FD disclosure Jul 20, 2026 8-K Director or officer change Jul 20, 2026 8-K Regulation FD disclosure Jul 13, 2026 8-K/A Director or officer change Jun 24, 2026 8-K Other events Jun 23, 2026 8-K Shareholder vote results Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure May 13, 2026 8-K Regulation FD disclosure May 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 27, 2026 8-K Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Mar 25, 2026 8-K Regulation FD disclosure Mar 19, 2026 8-K Regulation FD disclosure Feb 23, 2026 8-K Entered a material agreement Jan 26, 2026 8-K Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure Oct 22, 2025 8-K Regulation FD disclosure Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure Aug 12, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Regulation FD disclosure May 19, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Other events May 1, 2025 8-K Other events Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Results of operations (earnings release) Mar 21, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Mar 12, 2025 8-K Regulation FD disclosure Dec 19, 2024 8-K Director or officer change Dec 4, 2024 8-K Entered a material agreement; Director or officer change Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Regulation FD disclosure Nov 12, 2024 8-K Director or officer change Oct 3, 2024